P082 Validation of the Baveno VI criteria: identifying low risk cirrhotic patients not requiring endoscopic surveillance in a teaching hospital

IntroductionIn cirrhotic patients, oesophageal varices are one of the major causes of death (6-week mortality is between 17%-28%) and 5–11% of all cases of upper gastrointestinal bleeding (UGIB).Patients with cirrhosis undergo variceal surveillance with oesophago-gastroduodenoscopy (OGD) to reduce the risk of oesophageal variceal bleeding. Patients with compensated cirrhosis will undergo endoscopic variceal surveillance every 1–3 years depending on the presence of varices.OGD is a key diagnostic test with one of the longest waiting lists in the NHS and variceal surveillance contributes to the overall waits in upper GI endoscopy. It is therefore essential that the appropriate patients are captured in order to maximise both the efficacy of the service and also the financial cost of delivering the service.The Baveno VI criterion uses biochemical and non-invasive measurements to predict the presence of oesophageal varices in patients with compensated cirrhosis. Based on the criteria, a platelet count >150 x109/L and a Liver Stiffness Measurement (LSM)